Paushak Ltd

Paushak Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Paushak Ltd

₹ 5,129 -1.12%
26 Apr - close price
paushak.com BSE: 532742
About

Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]

Key Points

Products Offered
Paushak is part of the Alembic group of companies situated in Gujarat, India and is the largest specialty chemical company in India based on Phosgene Chemistry. Its products include Chloroformates, Isocyanates, Chlorides, Carbonates/Carbamate and Other Chemicals. These chemicals are used in diverse fields such as pesticides, pharmaceuticals dyes plastics and perfumeries. [1] [2]

Website BSE
  • Market Cap ₹ 1,581 Cr.
  • Current Price ₹ 5,129
  • High / Low ₹ 7,524 / 4,464
  • Stock P/E 31.3
  • Book Value ₹ 1,203
  • Dividend Yield 0.34 %
  • ROCE 20.5 %
  • ROE 15.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
40 39 23 41 34 53 50 50 56 56 49 52 52
26 22 18 23 22 32 32 33 35 37 36 38 33
Operating Profit 14 16 5 18 12 20 18 17 20 20 12 14 19
OPM % 35% 42% 21% 43% 34% 39% 37% 33% 37% 35% 25% 28% 36%
3 1 1 3 0 1 1 5 3 2 4 7 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 2 3 3 3 3 3 3 3 3 3
Profit before tax 16 16 4 19 9 18 16 18 20 19 12 18 18
Tax % 26% 32% 27% 26% 23% 26% 27% 27% 24% 23% 26% 25% 26%
12 11 3 14 7 13 12 13 15 14 9 13 14
EPS in Rs 37.44 35.72 9.51 46.33 23.30 42.89 37.47 42.47 48.73 46.56 29.66 43.25 44.22
Raw PDF
Upcoming result date: 3 May 2024

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
34 51 54 69 78 72 105 140 138 141 150 212 209
29 39 43 52 61 60 75 99 95 91 96 137 144
Operating Profit 5 12 11 17 17 12 29 40 43 50 54 75 65
OPM % 15% 23% 20% 25% 22% 17% 28% 29% 31% 36% 36% 35% 31%
1 1 4 3 3 5 3 13 7 6 5 11 16
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 3 3 3 4 4 5 9 13 14
Profit before tax 4 11 13 18 17 14 29 49 45 52 50 72 67
Tax % 17% 27% 30% 28% 25% 22% 26% 20% 23% 28% 25% 25%
3 8 9 13 12 11 21 39 35 37 38 54 50
EPS in Rs 10.76 24.29 27.50 40.50 38.73 34.11 66.95 126.41 113.27 121.02 122.03 175.24 163.69
Dividend Payout % 19% 12% 11% 7% 8% 9% 4% 4% 5% 5% 10% 10%
Compounded Sales Growth
10 Years: 15%
5 Years: 15%
3 Years: 15%
TTM: 0%
Compounded Profit Growth
10 Years: 21%
5 Years: 19%
3 Years: 16%
TTM: -2%
Stock Price CAGR
10 Years: 40%
5 Years: 19%
3 Years: -12%
1 Year: -30%
Return on Equity
10 Years: 16%
5 Years: 15%
3 Years: 14%
Last Year: 15%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 3 3 3 3 3 3 3 3 3 3 3 3 3
Reserves 28 35 42 54 65 80 110 174 224 269 302 351 368
3 1 0 0 1 0 1 0 0 0 0 0 0
7 8 8 11 13 11 31 36 43 57 61 61 63
Total Liabilities 41 47 54 69 82 94 144 214 270 329 367 415 434
11 10 9 18 20 35 37 38 41 51 147 149 145
CWIP 1 0 4 1 12 0 1 6 16 68 8 7 20
Investments 14 14 18 19 18 33 53 116 163 154 151 182 200
16 23 23 30 31 26 54 54 50 56 61 78 69
Total Assets 41 47 54 69 82 94 144 214 270 329 367 415 434

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
1 2 9 9 14 12 10 24 45 30 44 43
-1 0 -7 -8 -13 -11 -10 -0 -43 -29 -42 -38
-0 -3 -2 -1 -1 -2 -1 -23 -2 -2 -2 -4
Net Cash Flow 0 0 0 0 0 -0 0 0 0 -1 -0 0

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 81 102 96 114 97 83 135 85 69 85 97 90
Inventory Days 190 133 117 96 117 125 118 122 131 148 233 180
Days Payable 117 79 71 94 104 70 170 73 110 118 227 122
Cash Conversion Cycle 154 155 142 116 110 138 83 133 89 115 103 149
Working Capital Days 109 115 108 110 95 92 109 100 75 60 81 93
ROCE % 14% 30% 30% 32% 25% 12% 29% 27% 21% 20% 17% 21%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 66.97%
0.08% 0.04% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.02% 0.02% 0.02% 0.02%
0.00% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.11% 0.20%
32.95% 33.00% 33.03% 33.03% 33.03% 33.04% 33.02% 33.01% 33.01% 33.02% 32.89% 32.81%
No. of Shareholders 11,64911,36211,73912,38215,38617,64719,17719,43520,22821,46821,59222,503

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings